Travere Therapeutics Earnings
NASDAQ: TVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Fiscal period
Sep/2026
EPS estimate
$0.05
Travere Therapeutics earnings summary
Travere Therapeutics is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $0.05. In its most recent report on Aug 4, 2026 (Q2 2026), TVTX posted EPS of $-0.37. Revenue for the quarter was $169.6 million.
Across the last 16 reports, TVTX shares moved an average of 4.7% (in either direction) in the first trading session after results, rising 4 times and falling 12 times.
Summary generated from market data by MetaCap's automated system. Methodology
TVTX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-0.37 | — | +1.3% |
| May 4, 2026 | — | $-0.40 | — | -0.0% |
| Feb 19, 2026 | — | $0.04 | — | -2.0% |
| Oct 30, 2025 | — | $0.28 | — | -8.0% |
| Aug 6, 2025 | — | $-0.14 | — | +11.1% |
| May 1, 2025 | — | $-0.47 | — | -5.3% |
| Feb 21, 2025 | — | $-0.71 | — | -2.6% |
| Oct 31, 2024 | — | $-0.70 | — | +13.0% |
| Aug 1, 2024 | — | $-0.91 | — | -5.2% |
| May 6, 2024 | — | $-1.76 | — | -3.8% |
| Feb 20, 2024 | — | $-1.18 | — | -0.9% |
| Nov 7, 2023 | — | $1.97 | — | +4.8% |
| Aug 3, 2023 | — | $-1.13 | — | -0.2% |
| May 4, 2023 | — | $-1.27 | — | -6.0% |
| Oct 27, 2022 | — | $-1.09 | — | -9.5% |
| Aug 4, 2022 | — | $-1.05 | — | -0.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.